Your browser doesn't support javascript.
loading
Myeloid Sarcoma: Case Series with Unusual Locations.
Abedi, Akram; Namdari, Nasrin; Monabati, Ahmad; Safaei, Akbar; Rajabi, Parvin; Mokhtari, Maral.
Afiliación
  • Abedi A; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Namdari N; Department of Hematology and Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Monabati A; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Safaei A; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Rajabi P; Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mokhtari M; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Int J Hematol Oncol Stem Cell Res ; 17(4): 296-303, 2023 Oct 01.
Article en En | MEDLINE | ID: mdl-38076783
Myeloid sarcoma (MS) or chloroma is a localized mass composed of blastic cells of granulocytic lineage. It is a subtype of acute myeloid leukemia and usually presents as a complication of acute myeloid leukemia, myeloid dysplastic syndrome, or myeloproliferative disorder. MS occurs in 2.5-9.1% of patients with AML, precedes the clinical disease, coincidence with the onset or at relapse and in rare conditions, it can occur with no evidence of hematologic disorders. Here, we presented seven cases of MS in unusual locations or with rare presentations at presentation or relapse. We concluded that MS should be considered in the differential diagnosis of any high-grade tumor, especially in a patient with previous history of any myeloid neoplasm.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Int J Hematol Oncol Stem Cell Res Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Int J Hematol Oncol Stem Cell Res Año: 2023 Tipo del documento: Article País de afiliación: Irán